Clinical Trials Browser

Phase 2 × Suspended × Cetuximab × Clear all

NCT07042295 2026-05-27

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

Phase 2 Suspended

Locally Recurrent Skin Squamous Cell Carcinoma